Medicine and Dentistry
Anesthesiology
23%
Anesthetic Agent
11%
Anticoagulant
47%
Antithrombotic
23%
Apixaban
23%
Atrial Fibrillation
11%
BRCA1
47%
BRCA2
11%
Cardiac Catheterization
23%
Cardiology
11%
Chronic Kidney Disease
47%
Congestive Heart Failure
47%
Consumer
47%
Coronary Artery
23%
Cost-Effectiveness Analysis
57%
Dabigatran
11%
Direct Oral Anticoagulant
47%
Doppler Echocardiography
23%
Drug Therapy
23%
Drug-Eluting Stent
100%
Edoxaban
35%
Endoplasmic reticulum
23%
Endovascular Aneurysm Repair
15%
Everolimus
11%
Glomerular Filtration Rate
23%
Health Care Cost
74%
Health Technology
10%
Heart Muscle Biopsy
23%
Hyperuricemia
9%
Hypoparathyroidism
47%
Isotopes of Calcium
23%
Kidney Function
47%
Left Ventricle
23%
Logistic Regression Analysis
17%
Mastectomy
47%
Medical Device
47%
Medical Economics
11%
Morphology
23%
Myocardial Disease
23%
Odds Ratio
68%
Ovarian Cancer
7%
Percutaneous Aortic Valve Replacement
10%
Percutaneous Coronary Intervention
64%
Rapamycin
17%
Rivaroxaban
23%
Salpingooophorectomy
39%
Technology Assessment
10%
Two Dimensional Echocardiography
23%
Uric Acid
47%
Warfarin
11%
Keyphrases
Anesthetic Drugs
11%
Cardiac Catheterization
23%
Cardiac muscle
23%
Conjoint Analysis
8%
Coping Ability
31%
Differences in Perception
11%
Dilatation
23%
Doppler Echocardiography
23%
Endoplasmic Reticulum
23%
Health Organizations
15%
Heart Failure
47%
Hospital Administrators
23%
Hospital Selection
23%
Hospital Services
47%
Innovation Creation
47%
Job Stress Factors
15%
Left Ventricle
23%
Loyalty
47%
Medical Device Market
47%
Medical Information Service
47%
Medical Methods
11%
Medical Office
47%
Medical Perception
47%
Medical Representative
23%
Medication Schedule
11%
Metabolic Changes
23%
Morphological Changes
23%
Muscle Biopsy
23%
Myocardial Disease
23%
New Indication
11%
Non-affiliated
26%
Normal Coronary Arteries
23%
Nursing Performance
15%
Office System
47%
Organizational Commitment
47%
Organizational Environment
31%
Perception Gap
47%
Perfect Competition
47%
Permissible Range
11%
Primary Hypoparathyroidism
47%
Reimbursement Costs
47%
Risk Environment
15%
Sense of Coherence
31%
Serum Calcium
23%
Sickness Absence
47%
Two-dimensional Echocardiography
23%
Two-tier
11%
Valvular Disease
23%
Volume Operator
21%
Wastage
47%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
23%
Anesthetic Agent
47%
Aneurysm
47%
Anticoagulant Agent
47%
Apixaban
23%
Atrial Fibrillation
11%
Breast Cancer
47%
Cancer Incidence
23%
Cardiovascular Disease
47%
Chemotherapy
23%
Chronic Kidney Failure
47%
Dabigatran
11%
Direct Oral Anticoagulant
47%
Edoxaban
35%
Heart Disease
47%
Hormone Cancer Therapy
23%
Hyperuricemia
9%
Malignant Neoplasm
23%
Mortality Rate
23%
Ovary Cancer
47%
Rivaroxaban
23%
Uric Acid
47%
Vascular Disease
47%
Warfarin
11%
